Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

50 SPRAY GEL SUNSCREEN WITH INSTANT BRONZER - Health Canada Drug Approval Details

Approvals/Health Canada/50 SPRAY GEL SUNSCREEN WITH INSTANT BRONZER

Authorized

STANDARD

50 SPRAY GEL SUNSCREEN WITH INSTANT BRONZER

prime enterprises, llc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: e9714557eb5a0b17
Company: prime enterprises, llc
Type: Standard

Approval Details

Approval Id: e9714557eb5a0b17
Drug Approval Canada Name: 50 SPRAY GEL SUNSCREEN WITH INSTANT BRONZER
Product Name: 50 SPRAY GEL SUNSCREEN WITH INSTANT BRONZER
Status: Cancelled Post Market
Status Date: 2020-08-01
Original Market Date: 2018-11-19
Din: 02479400
Drug Class: Human
Dosage Form: Gel
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0451521009
Company Name: prime enterprises, llc
Company Address: 16363 Nw 49th Ave., Miami, Florida, United States, 33014

Active Ingredients

HOMOSALATE

10 %

OCTISALATE

5 %

AVOBENZONE

3 %

OCTOCRYLENE

2.75 %

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e9714557eb5a0b17

Type

Standard

Back to Health Canada Approvals